DK136157C - - Google Patents

Info

Publication number
DK136157C
DK136157C DK328673A DK328673A DK136157C DK 136157 C DK136157 C DK 136157C DK 328673 A DK328673 A DK 328673A DK 328673 A DK328673 A DK 328673A DK 136157 C DK136157 C DK 136157C
Authority
DK
Denmark
Application number
DK328673A
Other languages
Danish (da)
Other versions
DK136157B (da
Inventor
G H Phillipps
C E Newall
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DK136157B publication Critical patent/DK136157B/da
Application granted granted Critical
Publication of DK136157C publication Critical patent/DK136157C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK328673AA 1972-06-15 1973-06-14 Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf. DK136157B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (2)

Publication Number Publication Date
DK136157B DK136157B (da) 1977-08-22
DK136157C true DK136157C (enExample) 1978-01-23

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK328673AA DK136157B (da) 1972-06-15 1973-06-14 Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-17beta-karboxylsyrederivater af androstanrækken eller salte deraf.

Country Status (9)

Country Link
BE (1) BE800899R (enExample)
CA (1) CA1040619A (enExample)
DE (1) DE2330342A1 (enExample)
DK (1) DK136157B (enExample)
FR (1) FR2189034B2 (enExample)
GB (1) GB1434919A (enExample)
LU (1) LU67790A1 (enExample)
NL (1) NL7308267A (enExample)
ZA (1) ZA734037B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169832A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
HRP20210610T1 (hr) * 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP4275748A3 (en) 2014-10-16 2024-01-03 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3885352B1 (en) 2014-10-16 2024-11-27 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
CA1040619A (en) 1978-10-17
AU5693773A (en) 1974-12-19
FR2189034B2 (enExample) 1977-01-21
GB1434919A (en) 1976-05-12
FR2189034A2 (enExample) 1974-01-25
LU67790A1 (enExample) 1973-08-16
DK136157B (da) 1977-08-22
DE2330342A1 (de) 1974-01-17
ZA734037B (en) 1974-05-29
NL7308267A (enExample) 1973-12-18
BE800899R (fr) 1973-12-14

Similar Documents

Publication Publication Date Title
JPS5237520Y2 (enExample)
CS153284B1 (enExample)
CS152035B1 (enExample)
CS153294B1 (enExample)
CS151398B1 (enExample)
CS152982B2 (enExample)
CS152733B1 (enExample)
CS153432B2 (enExample)
CS152246B1 (enExample)
CS152722B1 (enExample)
CS152200B1 (enExample)
CS152719B1 (enExample)
CS153726B1 (enExample)
CS151848B1 (enExample)
CS151836B1 (enExample)
CS151679B1 (enExample)
CH563551A5 (enExample)
CH596308A5 (enExample)
CH567700A5 (enExample)
CH567892A5 (enExample)
CH579635A5 (enExample)
CH580369A5 (enExample)
CH580681A5 (enExample)
CH580903A5 (enExample)
CH581190A5 (enExample)